Last Updated on January 21, 2024 by The Health Master
The Haryana government has received an expression of interest from an international pharma company headquartered in Malta to provide up to 60 million doses of Sputnik V vaccine to the state, it said.
The state had floated a global tender for C-19 vaccine shots through the Haryana Medical Services Corporation (HMSCL) on May 26. The tender was closed on June 4, but no bid was received during the period, the government said in a statement.
However, the Pharma Regulatory Services Limited in Malta has given an expression of interest to the HMSCL to provide doses of Sputnik V vaccine manufactured by the Gamaleya Institute and the Russian Direct Investment Fund (RDIF), it said.
Sputnik V is one of the three vaccines approved by India’s drug controller (DCGI) for use in the country. As per the offer made by the firm, each dose of the vaccine will cost Rs 1,120, the statement said.
The firm has given a timeline of 30 days to supply the first batch of five lakh doses, followed by 10 lakh doses every 20 days till the supply is completed, against a letter of credit issued in its name, the government said.
Schedules – Drugs and Cosmetics Act 1940 and Rules 1945
Overcharging: Haryana plans surgical strike on Hospitals
Serum gets nod from DCGI to produce Sputnik V vaccine in…
Recovered C-19 patients must take this medicine for 2-3 months
Dos and don’ts of CT scanning in C-19
Glenmark gets USFDA nod for Theophylline ER tablets
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
